These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 11026692)

  • 1. The prognostic significance of vascular endothelial growth factor (VEGF C-1) immunoexpression in oligodendroglioma. An analysis of 91 cases.
    Korshunov A; Golanov A
    J Neurooncol; 2000 May; 48(1):13-9. PubMed ID: 11026692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular endothelial growth factor expression in oligodendrogliomas: a correlative study with Sainte-Anne malignancy grade, growth fraction and patient survival.
    Varlet P; Guillamo JS; Nataf F; Koziak M; Beuvon F; Daumas-Duport C
    Neuropathol Appl Neurobiol; 2000 Aug; 26(4):379-89. PubMed ID: 10931372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of vascular endothelial growth factor and its receptors in the anaplastic progression of astrocytoma, oligodendroglioma, and ependymoma.
    Chan AS; Leung SY; Wong MP; Yuen ST; Cheung N; Fan YW; Chung LP
    Am J Surg Pathol; 1998 Jul; 22(7):816-26. PubMed ID: 9669344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical detection of vascular endothelial growth factor (VEGF) in the vasculature of oligodendrogliomas.
    Christov C; Adle-Biassette H; Le Guerinel C; Natchev S; Gherardi RK
    Neuropathol Appl Neurobiol; 1998 Feb; 24(1):29-35. PubMed ID: 9549726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of cell proliferation, epidermal growth factor receptor, and bcl-2 immunoexpression as prognostic factors for patients with World Health Organization grade 2 oligodendroglioma.
    Reis-Filho JS; Faoro LN; Carrilho C; Bleggi-Torres LF; Schmitt FC
    Cancer; 2000 Feb; 88(4):862-9. PubMed ID: 10679656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of clinical and angiogenesis-related factors in low-grade oligodendrogliomas.
    Vaquero J; Zurita M; Coca S; Oya S; Morales C
    Surg Neurol; 2000 Sep; 54(3):229-34; discussion 234. PubMed ID: 11118569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular endothelial growth factor (VEGF) in astrocytic gliomas--a prognostic factor?
    Oehring RD; Miletic M; Valter MM; Pietsch T; Neumann J; Fimmers R; Schlegel U
    J Neurooncol; 1999; 45(2):117-25. PubMed ID: 10778727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical markers for prognosis of oligodendroglial neoplasms.
    Korshunov A; Golanov A; Sycheva R
    J Neurooncol; 2002 Jul; 58(3):237-53. PubMed ID: 12187958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma.
    Gasparini G; Toi M; Gion M; Verderio P; Dittadi R; Hanatani M; Matsubara I; Vinante O; Bonoldi E; Boracchi P; Gatti C; Suzuki H; Tominaga T
    J Natl Cancer Inst; 1997 Jan; 89(2):139-47. PubMed ID: 8998183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with low-grade astrocytoma.
    Abdulrauf SI; Edvardsen K; Ho KL; Yang XY; Rock JP; Rosenblum ML
    J Neurosurg; 1998 Mar; 88(3):513-20. PubMed ID: 9488306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VEGF, flt-1, and KDR/flk-1 as prognostic indicators in endometrial carcinoma.
    Fine BA; Valente PT; Feinstein GI; Dey T
    Gynecol Oncol; 2000 Jan; 76(1):33-9. PubMed ID: 10620438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of bFGF, FGFR-1 and VEGF expression with vascularity and malignancy of human astrocytomas.
    Bian XW; Du LL; Shi JQ; Cheng YS; Liu FX
    Anal Quant Cytol Histol; 2000 Jun; 22(3):267-74. PubMed ID: 10872046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic significance of DNA topoisomerase II-alpha (Ki-S1), p21/Cip-1, and p27/Kip-1 protein immunoexpression in oligodendrogliomas.
    Korshunov A; Golanov A
    Arch Pathol Lab Med; 2001 Jul; 125(7):892-8. PubMed ID: 11419973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oligodendrogliomas in relation to astrocytes differentiation. Clinicopathologic and immunohistochemical study.
    Tena-Suck ML; Moreno-Jiménez S; Alonso M; Aguirre-Crux L; Sánchez A
    Ann Diagn Pathol; 2008 Oct; 12(5):313-21. PubMed ID: 18774492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial growth factor expression, vascular volume, and, capillary permeability in human brain tumors.
    Machein MR; Kullmer J; Fiebich BL; Plate KH; Warnke PC
    Neurosurgery; 1999 Apr; 44(4):732-40; discussion 740-1. PubMed ID: 10201297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of vascular endothelial growth factor correlates with tumor progression in gallbladder cancer.
    Okita S; Kondoh S; Shiraishi K; Kaino S; Hatano S; Okita K
    Int J Oncol; 1998 May; 12(5):1013-8. PubMed ID: 9538121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of vascular endothelial growth factor expression in human ovarian carcinoma.
    Shen GH; Ghazizadeh M; Kawanami O; Shimizu H; Jin E; Araki T; Sugisaki Y
    Br J Cancer; 2000 Jul; 83(2):196-203. PubMed ID: 10901370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of vascular endothelial growth factor (VEGF) in head and neck squamous cell carcinomas.
    Mineta H; Miura K; Ogino T; Takebayashi S; Misawa K; Ueda Y; Suzuki I; Dictor M; Borg A; Wennerberg J
    Br J Cancer; 2000 Sep; 83(6):775-81. PubMed ID: 10952783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial growth factor expression in early stage ovarian carcinoma.
    Paley PJ; Staskus KA; Gebhard K; Mohanraj D; Twiggs LB; Carson LF; Ramakrishnan S
    Cancer; 1997 Jul; 80(1):98-106. PubMed ID: 9210714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of nitric oxide synthase isozymes (NOS I-III) by immunohistochemistry and DNA in situ hybridization. Correlation with macrophage presence, vascular endothelial growth factor (VEGF) and oedema volumetric data in 220 glioblastomas.
    Ludwig HC; Feiz-Erfan I; Bockermann V; Behnke-Mursch J; Schallock K; Markakis E
    Anticancer Res; 2000; 20(1A):299-304. PubMed ID: 10769671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.